U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Dec 16 13:58:38 GMT 2023
Edited
by admin
on Sat Dec 16 13:58:38 GMT 2023
Protein Type FC FUSION PROTEIN
Protein Sub Type T-CELL ANTIGEN
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
N658GY6L3E
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
TEBENTAFUSP
USAN   INN  
Official Name English
Tebentafusp [WHO-DD]
Common Name English
IMCGP-100
Code English
T CELL RECEPTOR .ALPHA. CHAIN (SYNTHETIC HUMAN) FUSION PROTEIN WITH T CELL RECEPTOR .BETA. CHAIN (SYNTHETIC HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN, ANTI-(HUMAN CD3 ANTIGEN) (SYNTHETIC SCFV FRAGMENT)
Common Name English
tebentafusp [INN]
Common Name English
IMMTAC IMCGP100
Code English
IMCGP100
Code English
TEBENTAFUSP [USAN]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 503615
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
Code System Code Type Description
FDA UNII
N658GY6L3E
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
USAN
GH-27
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
CAS
1874157-95-5
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
INN
10664
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
NCI_THESAURUS
C94208
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
DAILYMED
N658GY6L3E
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
RXCUI
2590743
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
DRUG BANK
DB15283
Created by admin on Sat Dec 16 13:58:38 GMT 2023 , Edited by admin on Sat Dec 16 13:58:38 GMT 2023
PRIMARY
From To
1_23 1_88
1_153 1_227
1_281 1_349
1_401 1_466
1_427 2_157
2_23 2_89
2_132 2_182
Related Record Type Details
TARGET -> AGONIST
BINDING
TARGET->ANTIGEN
HLA-A2 restricted melanoma gp100 peptide (YLEPGPVTA)
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL